Baby boomers have become a growing market segment in the legal cannabis industry as the acceptance of medical cannabis treatment continues to spread across the world, and now it appears that medical cannabis treatment may offer senior citizens a safer alternative to opioids in the treatment of chronic pain.
Tag Archives: Chronic Pain
OTTAWA, Ontario, Jan. 29, 2018 /Weed Wire/ – Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX VENTURE:TBP)(OTCQB:TBPMF), a global leader in cannabinoid-based drug development and discovery, is pleased to announce the approval by Health Canada of a Phase 2 clinical trial designed to evaluate the safety and efficacy of different doses and ratios of medical cannabis oil (THC & CBD) to improve uncontrolled chronic pain in cancer and non-cancer patients.
Soon, Oklahomans will vote on legalizing medical marijuana, but many are already finding relief with CBD oil.
Illinois patients suffering from chronic pain may soon have a new way to treat their medical condition. On Jan. 16, 2018, Cook County Judge Raymond Mitchell ordered the Illinois Department of Public Health to add chronic pain as a qualifying condition for the state’s medical marijuana program.
A landmark federal report released in 2017 outlined what’s known about the potential health benefits and risks of marijuana use.
The Department of Veterans Affairs says it will not conduct research into whether medical marijuana could help veterans suffering from post-traumatic stress disorder and chronic pain, as veterans groups are pushing for the use of the drug as an alternative to opioids and anti-depressants.
WELLINGTON, Dec. 21, 2017 /Weed Wire/ — The Green Party is supporting the Government’s medicinal cannabis legislation introduced to parliament today, but is encouraging the public to use the select committee process to push for improvements to expand the law.
Medical cannabis cards in the Mountain State won’t see the light of day until July 1, 2019, but it appears prospective patients might have an easier time finding a West Virginia medical cannabis doctor.
Minnesota medical marijuana patients are worried after news broke that one of the state’s two cannabis providers is experiencing a distribution delay, leaving them with scarce supplies for treatment.
Medical marijuana may help reduce opioid addiction in patients suffering from chronic pain, according to a new study published in the open access journal PLOS ONE.
CARABOODA, Western Australia, Nov. 22, 2017 /Weed Wire/ — AusCann Group Holdings Ltd (ASX:AC8 or ‘the Company’) is pleased to announce that its joint venture (JV) in Chile, DayaCann, has secured a further licence for the cultivation of medical cannabis crops at its Chilean facility.
A group of 10 U.S. House members is pushing the Trump administration to begin researching medical marijuana’s potential benefits for military veterans struggling to cope with war wounds.
As the state’s medical marijuana program edges closer to kickoff, only two Louisiana doctors in the state have applied for permission to dispense the drug.
Five months ago, a New Jersey health panel voted in favor of dramatically expanding the list of conditions that may be treated with cannabis. Chronic pain, Alzheimer’s, autism, anxiety, migraines, and other maladies should be added to the list of 13 ailments, said the panel of doctors and other health professionals.
CHICAGO, Sept.18, 2017 /Weed Wire/ – A bipartisan group of senators led by Brian Schatz (D-Hawaii) has reintroduced the Marijuana Effective Studies Act of 2016 (MEDS Act), which will remove excessive regulatory barriers inhibiting researchers from obtaining marijuana plants to conduct studies assessing the drug’s medical effectiveness and safety.
Even though pain and posttraumatic stress disorder (PTSD) are among the most common reasons people use medical marijuana in the U.S., there isn’t much proof cannabis works for either one of these conditions, two research reviews suggest.
Seniors are becoming as the fastest growing segment of the marijuana industry. According to a national survey, usage among adults 65 and older is up 250 percent, while adults 50-65 have also increased usage nearly 58 percent.
On Aug. 8, 2017, Albert Einstein College of Medicine and Montefiore Health System announced that they had received a grant from the National Institutes of Health to conduct a long-term study on how medical cannabis affects opioid use in adults with chronic pain.
BRONX, N.Y., Aug. 8, 2017 /Weed Wire/ — The National Institutes of Health (NIH) has awarded researchers at Albert Einstein College of Medicine and Montefiore Health System a five-year, $3.8 million grant for the first long-term study to test whether me
On July 25, 2017, the New Jersey Medicinal Marijuana Program Review Panel revealed an initial recommendation to add migraines, Tourette’s Syndrome, chronic pain and anxiety to the list of qualifying conditions for those seeking medical marijuana treatment in the Garden State.
Today, the New Jersey Medicinal Marijuana Program Review Panel made initial recommendations to the Health Commissioner to approve chronic pain, migraine, anxiety and Tourette’s Syndrome as qualifying conditions for the medical marijuana program.
ATHENS, Greece, June 30, 2017 /Weed Wire/ — Published today in the Official Gazette, Joint Ministerial Decision (JMD) Ministers of Health and Justice, which opens the way for the introduction of approved medications and hemp products. These formulations are indicated for cases that have proven clinical benefit for a variety of diseases such as chronic pain, neuropathic pain, nausea and vomiting due to chemotherapy, cachexia / anorexia. etc.
Utah medical marijuana legalization is gaining traction. On June 27, 2017, the Utah Patients Coalition announced that a majority of voters support medical marijuana legalization via a state ballot initiative.
NEW YORK, June 23, 2017 /Weed Wire/ — AXIM Biotechnologies, Inc. (AXIM Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that the company filed with the United States Patent and Trademark Office (USPTO) for U.S. Application Serial Number 62/410,469, a patent of invention that involves a chewing gum composition with controlled release of cannabinoids and opioid agonists and/or antagonists for addiction and/or dependence treatment.
ALBANY, N.Y., June 22, 2017 /Weed Wire/ – The New York State Department of Health (NYSDOH) today announced several new enhancements to the state’s Medical Marijuana Program as the number of certified patients continues to rise since the addition of chronic pain as a qualifying condition.
CHICAGO, Ill., May 23, 2017 /Weed Wire/ — Aclara Research, a leader in the development of patient and consumer insights within the medical cannabis industry, today released the results of The Illinois Medical Cannabis Patient Experience Study – the first of Illinois patients since the inception of the pilot program in 2012.
New Jersey might get an influx of new medical marijuana patients. On May 11, 2017, the New Jersey Medicinal Marijuana Program Review Panel suggested that the state health commissioner add chronic pain as a qualifying condition.
TRENTON, N.J., May 11, 2017 /Weed Wire/ — Today, the New Jersey Medicinal Marijuana Program Review Panel made initial recommendations to the Health Commissioner to approve chronic pain related to musculoskeletal disorders, migraines, anxiety, chronic fatigue related to ailments such as irritable bowel syndrome, Tourrette syndrome as qualifying conditions for the medical marijuana program.
On May 5, 2017, the New York State Department of Health gave additional transparency to its program by adding registration statistics and a public list of consenting medical marijuana doctors to the program’s website.
ALBANY, New York, May 5, 2017 /Weed Wire/ — The New York State Department of Health today announced several milestones in the state’s Medical Marijuana program, including the certification of more than 3,350 patients since the addition of chronic pain as a qualifying condition in late March.
On May 2, 2017, the Florida House of Representatives voted to approve House Bill 1397, a bill that would regulate the state’s developing medical marijuana program.
According to a study recently published by the International Journal of Drug Policy, patients in Canada are substituting marijuana for opioids, benzodiazepines and antidepressants for symptom relief from pain and mental health conditions.
As Gov. Chris Christie travels the state on an aggressive campaign to end an epidemic of heroin and prescription drug overdoses, more than two dozen New Jersey citizens came to the capital city Wednesday to offer him a new strategy.
A comprehensive study slams many of the alleged benefits of marijuana and points to serious negative effects. What will the impact of this study be for marijuana stocks?
The National Academics of Sciences, Engineering and Medicine has released a 395-page report that looks at a wide range of scientific evidence on the effectiveness of marijuana as medicine. “The Health Effects of Cannabis and Cannabinoids” provides “a comprehensive review of scientific evidence related to the health effects and potential therapeutic benefits of cannabis.”
A large group of Florida doctors are going through the certification process to prescribe medical marijuana to patients, just days before legalization goes through.
ALBANY, N.Y., Dec. 8, 2016 /Weed Wire/ — The New York State Department of Health today announced several enhancements to the state’s Medical Marijuana Program that will improve access for patients, streamline production, increase choice and help lead to reduced costs.
On Dec. 1, 2016, the New York State Department of Health announced that it will be adding chronic pain to the list of qualifying conditions for medical marijuana.
NEW YORK, Dec. 1, 2016 /Weed Wire/ — The New York State Department of Health today announced that chronic pain will be added as a qualifying condition for medical marijuana.
A new study suggests legalized medical marijuana could be the answer to the ongoing opioid crisis in the United States, according to a Sept. 17, 2016, article at The Huffington Post. The study examined traffic fatalities in 18 states 1999-2013. Researchers noticed states with legalized medical marijuana saw a drop in accidents in which the driver had been taking an opioid.
MINNEAPOLIS (AP) – Nearly 500 patients suffering intractable pain have registered to buy medical marijuana starting Monday.
If you have a medical condition that could possibly be treated with medical marijuana, the state of New Jersey wants to hear from you.
On June 6, 2016, Gov. Peter Shumlin signed S. 14, a law that permits medical marijuana access for state residents under hospice care, as well as access to those with glaucoma or chronic pain.
On April 7, 2016, the South Carolina Senate Medical Affairs Committee rejected S 0672, a bill that would legalize medical marijuana for patients suffering from debilitating conditions, such as cancer, PTSD, and chronic pain.
A National Football League team is demanding that another group change its logo, claiming that the Pittsburgh chapter of the National Organization for the Reform of Marijuana Laws (better known as NORML) logo, which basically looks just like the Steelers logo with the throwing-star things swapped out for marijuana leaves.
It has been 15 years since the advent of medical marijuana in the United States. A new study published by JAMA Internal Medicine sought to determine the effect the availability of legal medical marijuana has on the rate of opioid overdoses in states where patients have access to medical marijuana.